Lipoteichoic Acid from Heyndrickxia coagulans HOM5301 Modulates the Immune Response of RAW 264.7 Macrophages
Nutrients · 2024
DOI: 10.3390/nu16173014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Shiqi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China. Hauptthemen laut MEDLINE: Teichoic Acids, Lipopolysaccharides, Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Coree Beijing Co., Ltd.
Abstract (Originalsprache)
Heyndrickxia coagulans (formerly Bacillus coagulans) has been increasingly utilized as an immunomodulatory probiotics. Oral administration of H. coagulans HOM5301 significantly boosted both innate and adaptive immunity in mice, particularly by increasing the phagocytic capacity of monocytes/macrophages. Lipoteichoic acid (LTA), a major microbe-associated molecular pattern (MAMP) in Gram-positive bacteria, exhibits differential immunomodulatory effects due to its structural heterogeneity. We extracted, purified, and characterized LTA from H. coagulans HOM5301. The results showed that HOM5301 LTA consists of a glycerophosphate backbone. Its molecular weight is in the range of 10–16 kDa. HOM5301 LTA induced greater productions of nitric oxide, TNFα, and IL-6 in RAW 264.7 macrophages compared to Staphylococcus aureus LTA. Comparative transcriptome and proteome analyses identified the differentially expressed genes and proteins triggered by HOM5301 LTA. KEGG analyses revealed that HOM5301 LTA transcriptionally and translationally activated macrophages through two immune-related pathways: cytokine–cytokine receptor interaction and phagosome formation. Protein–protein interaction network analysis indicated that the pro-inflammatory response elicited by HOM5301 LTA was TLR2-dependent, possibly requiring the coreceptor CD14, and is mediated via the MAPK and NF-kappaB pathways. Our results demonstrate that LTA is an important MAMP of H. coagulans HOM5301 that boosts immune responses, suggesting that HOM5301 LTA may be a promising immunoadjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
- Food & Biotech R&D Center, Coree Beijing Co., Ltd., Beijing 101312, China.
- Key Laboratory of Precision Nutrition and Food Quality, Department of Nutrition and Healthy, China Agricultural University, Beijing 100083, China.
- College of Engineering, China Agricultural University, Beijing 100083, China.
ORCID-Profile: Shiqi Zhang, Nan Shang
Förderung
- National Natural Science Foundation of China
- Coree Beijing Co., Ltd
Zitieren
APA
Zhang, S., Li, P., Zhang, X., Ding, Y., Wang, T., Lee, S., Xu, Y., Lim, C., & Shang, N. (2024). Lipoteichoic Acid from Heyndrickxia coagulans HOM5301 Modulates the Immune Response of RAW 264.7 Macrophages. Nutrients. https://doi.org/10.3390/nu16173014
Vancouver
Zhang S, Li P, Zhang X, Ding Y, Wang T, Lee S, et al. Lipoteichoic Acid from Heyndrickxia coagulans HOM5301 Modulates the Immune Response of RAW 264.7 Macrophages. Nutrients. 2024. doi:10.3390/nu16173014
BibTeX
@article{Zhang2024,
author = {Zhang, Shiqi and Li, Pinglan and Zhang, Xiao and Ding, Yan and Wang, Tingting and Lee, Suwon and Xu, Ying and Lim, Chongyoon and Shang, Nan},
title = {Lipoteichoic Acid from Heyndrickxia coagulans HOM5301 Modulates the Immune Response of RAW 264.7 Macrophages},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16173014}
}
EUVIMED